FOS and Alpers syndrome: Control tissues showed low levels of c‐fos+ immunoreactivity as expected (Figure 5A), whereas a higher density of c‐fos+ cells was observed in tissues from patients with SUDEP (Figure 5B) and Alpers' syndrome (Figure 5C–G).